SFRT+Sequential Hypofractionated/Conventional Fractionated RT+Iparomlimab and Tuvonralimab for Relapsed/Refractory Solid Tumors
Clinical trial NCT06936748 · RECRUITING
Trial details
- NCT number
- NCT06936748
- Sponsor
- Second Affiliated Hospital of Nanchang University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-20
- Primary completion
- 2028-06-19
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.